Back
Direxion Daily S&P Biotech Bear 3X ETF Vs. Expedia Group Industry Stock Comparison
Sell
5
LABD
Direxion Daily S&P Biotech Bear 3X ETF
Last Price:
7.96
Seasonality Move:
-25.41%
Sell
48
EXPE
Expedia Group
Last Price:
113.98
Seasonality Move:
8.66%
Sell
5
Direxion Daily S&P Biotech Bear 3X ETF (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P Biotech Bear 3X ETF [LABD] share price is $7.95. The Score for LABD is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- LABD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $114.01. The Score for EXPE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X ETF's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X ETF share price today is $7.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $114.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
LABD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 42.48 | Sell |
| Chaikin Money Flow: | 6696108 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.16 - 10.28) | Sell |
| Bollinger Bands (100): | (7.38 - 9.82) | Sell |
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.51 | Sell |
| Relative Strength Index (14 RSI): | 32.68 | Sell |
| Chaikin Money Flow: | 1004127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.28 - 134.18) | Sell |
| Bollinger Bands (100): | (125.67 - 148.45) | Sell |
LABD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.18 | Sell |
| 20-day SMA: | 9 | Sell |
| 50-day SMA: | 8.48 | Sell |
| 200-day SMA: | 13.81 | Sell |
| 8-day EMA: | 8.11 | Sell |
| 20-day EMA: | 8.56 | Sell |
| 50-day EMA: | 8.76 | Sell |
| 200-day EMA: | 12.22 | Sell |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.87 | Buy |
| 20-day SMA: | 123.1 | Sell |
| 50-day SMA: | 129.38 | Sell |
| 200-day SMA: | 125.89 | Sell |
| 8-day EMA: | 114.63 | Sell |
| 20-day EMA: | 120.08 | Sell |
| 50-day EMA: | 127.21 | Sell |
| 200-day EMA: | 126.93 | Sell |
Direxion Daily S&P Biotech Bear 3X ETF Earnings Growth & LABD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
Direxion Daily S&P Biotech Bear 3X ETF Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Expedia Group Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||